Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renin-angiotensin system: Meta-analyses can misdirect decisions on treatment.

Literature DB >> 23629638

Renin-angiotensin system: Meta-analyses can misdirect decisions on treatment.

Piero Ruggenenti¹, Giuseppe Remuzzi.

Abstract

Mesh：

Substances：

Year: 2013 PMID： 23629638 DOI： 10.1038/nrneph.2013.82

Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314

× No keyword cloud information.

10 in total

Review 1. Proteinuria should be used as a surrogate in CKD.

Authors: Paolo Cravedi; Piero Ruggenenti; Giuseppe Remuzzi
Journal: Nat Rev Nephrol Date: 2012-03-06 Impact factor: 28.314

2. Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: sensitisation of the Bezold-Jarisch reflex?

Authors: Peter Sever
Journal: J Renin Angiotensin Aldosterone Syst Date: 2013-03 Impact factor: 1.636

3. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.

Authors: J Ménard; D J Campbell; M Azizi; M F Gonzales
Journal: Circulation Date: 1997-11-04 Impact factor: 29.690

Review 4. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Authors: Christian Werner; Magnus Baumhäkel; Koon K Teo; Roland Schmieder; Johannes Mann; Thomas Unger; Salim Yusuf; Michael Böhm
Journal: Clin Res Cardiol Date: 2008-05-03 Impact factor: 5.460

5. Role of remission clinics in the longitudinal treatment of CKD.

Authors: Piero Ruggenenti; Elena Perticucci; Paolo Cravedi; Vincenzo Gambara; Marco Costantini; Sanjib Kumar Sharma; Annalisa Perna; Giuseppe Remuzzi
Journal: J Am Soc Nephrol Date: 2008-03-19 Impact factor: 10.121

6. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.

Authors: Carla Zoja; Daniela Corna; Davide Camozzi; Dario Cattaneo; Daniela Rottoli; Cristian Batani; Cristina Zanchi; Mauro Abbate; Giuseppe Remuzzi
Journal: J Am Soc Nephrol Date: 2002-12 Impact factor: 10.121

7. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Authors: John J V McMurray; Jan Ostergren; Karl Swedberg; Christopher B Granger; Peter Held; Eric L Michelson; Bertil Olofsson; Salim Yusuf; Marc A Pfeffer
Journal: Lancet Date: 2003-09-06 Impact factor: 79.321

Review 8. Mechanisms and treatment of CKD.

Authors: Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal: J Am Soc Nephrol Date: 2012-10-25 Impact factor: 10.121

9. Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Authors: Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Frederik Persson; Akshay S Desai; Maria Nicolaides; Alexia Richard; Zhihua Xiang; Patrick Brunel; Marc A Pfeffer
Journal: N Engl J Med Date: 2012-11-03 Impact factor: 91.245

Review 10. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.

Authors: Harikrishna Makani; Sripal Bangalore; Kavit A Desouza; Arpit Shah; Franz H Messerli
Journal: BMJ Date: 2013-01-28